| scholarly article | Q13442814 |
| P2093 | author name string | Christopher T Minson | |
| Britta N Torgrimson | |||
| Jessica R Meendering | |||
| Nicole P Miller | |||
| Paul F Kaplan | |||
| P2860 | cites work | Hormone replacement therapy modifies the capacity of plasma and serum to regulate prostacyclin and endothelin-1 production in human vascular endothelial cells | Q71380555 |
| Risk of venous thromboembolism in users of hormone replacement therapy | Q71652383 | ||
| Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery: possible role of estrogen and nitric oxide | Q71862683 | ||
| Risk of thromboembolic disease in women taking oral contraceptives. A preliminary communication to the Medical Research Council by a Subcommittee | Q72216125 | ||
| Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial | Q72375182 | ||
| Modulation of plasma endothelin levels by the menstrual cycle | Q73833783 | ||
| Flow-mediated dilation in human brachial artery after different circulatory occlusion conditions | Q73881217 | ||
| The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels | Q74244438 | ||
| Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation | Q74338330 | ||
| Cholesterol, endothelial function and cardiovascular disease | Q74724206 | ||
| Effect of the menstrual cycle on endothelium-dependent vasodilation of the brachial artery in normal young women | Q74809014 | ||
| Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide | Q77296009 | ||
| Cholesterol, cholesterol lowering, and endothelial function | Q77470452 | ||
| Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm | Q78020361 | ||
| Decrease in endothelin-1 plasma levels during the menstrual cycle and after ethinylestradiol treatment | Q78215795 | ||
| Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol | Q79717800 | ||
| Impact of controlling shear rate on flow-mediated dilation responses in the brachial artery of humans | Q79871172 | ||
| Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women | Q28378766 | ||
| Cholesterol lowering and endothelial function | Q33777699 | ||
| Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women | Q34447831 | ||
| Protective effects of estrogen on the cardiovascular system | Q34524567 | ||
| Estrogens and the vascular endothelium | Q34735576 | ||
| The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function | Q36211375 | ||
| Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease | Q38515512 | ||
| Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force | Q39605814 | ||
| Oral contraceptives, lipids and cardiovascular disease | Q39614304 | ||
| Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women | Q40115916 | ||
| Oral contraceptive use and fasting triglyceride, plasma cholesterol and HDL cholesterol | Q40237355 | ||
| The ORTHO BC-SAT--a satisfaction questionnaire for women using hormonal contraceptives | Q40280602 | ||
| Population-based study of risk of venous thromboembolism associated with various oral contraceptives | Q40907056 | ||
| The vascular protective effects of estrogen. | Q40981997 | ||
| Endothelial control of the cardiovascular system: recent advances | Q40993772 | ||
| The atherogenic potential of endothelin. | Q41025598 | ||
| Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis | Q41160044 | ||
| Endothelin in Coronary Endothelial Dysfunction and Early Atherosclerosis in Humans | Q41671991 | ||
| Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive. | Q42166526 | ||
| Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive | Q42520831 | ||
| Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease | Q43614603 | ||
| Association between wall shear stress and flow-mediated vasodilation in healthy men. | Q43614863 | ||
| Improved analysis of brachial artery ultrasound using a novel edge-detection software system | Q43678660 | ||
| Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII. | Q43865734 | ||
| Effect of two oral contraceptives with different ethinyl estradiol and levonorgestrel concentrations on the urinary excretion of biochemical vasoactive markers | Q43880260 | ||
| Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures | Q44040131 | ||
| Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins | Q44181135 | ||
| Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women | Q44679350 | ||
| Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile | Q45168758 | ||
| Measuring peripheral resistance and conduit arterial structure in humans using Doppler ultrasound | Q45251353 | ||
| Effects of low dose oral contraceptives on serum total cholesterol, TAG, HDL-C & LDL-C levels in contraceptive users | Q45254262 | ||
| Menopause and risk of cardiovascular disease: the Framingham study. | Q50870268 | ||
| Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. | Q50928581 | ||
| Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. | Q51049618 | ||
| Flow- and agonist-mediated nitric oxide- and prostaglandin-dependent dilation in spinal arteries. | Q54151734 | ||
| Acute vascular effects of estrogen in postmenopausal women. | Q54198181 | ||
| Oral Contraceptive and Postmenopausal Estrogen Effects on Lipoprotein Triglyceride and Cholesterol in an Adult Female Population: Relationships to Estrogen and Progestin Potency* | Q70976365 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 441-447 | |
| P577 | publication date | 2008-08-15 | |
| P1433 | published in | Fertility and Sterility | Q15724525 |
| P1476 | title | Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring | |
| P478 | volume | 92 |
| Q34145361 | A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation |
| Q35396665 | Short-term oral progesterone administration antagonizes the effect of transdermal estradiol on endothelium-dependent vasodilation in young healthy women |
Search more.